Birdwatch Note Rating
2024-08-14 08:18:12 UTC - NOT_HELPFUL
Rated by Participant: B383C69379C598ED35A46E582C30251A79404923F438D3869EC65983B65069A5
Participant Details
Original Note:
The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation
All Note Details